Timothy M. Bateman, MD

Timothy M. Bateman, M.D. is co-director of Cardiovascular Radiologic Imaging Program at Saint Luke's and is professor of medicine at the University of Missouri-Kansas City School of Medicine. He is past-president of the American Society of Nuclear Cardiology, current president of the InterSocietal Commission for the Accreditation of CT Laboratories, a board member of the InterSocietal Accreditation Commission, and a board member of the American Board of Internal Medicine-Cardiovascular Diseases.

He is an editorial consultant for eleven major medical journals and has authored/coauthored over 500 book chapters, peer reviewed publications and abstracts. He has been honored with numerous awards, including  "50 Best Doctors in Kansas City" in 2002,2004,2006,2009, and 2011 and the Distinguished Service Award of the American Society of Nuclear Cardiology in 2005. His practice commitment and research interests are focused on appropriate utilization and optimization of cardiac imaging technologies for answering major clinical questions.

1) Czer L, Matloff J, Gray R, Bateman TM, Chaux A:  Mitral valve replacement with coronary artery disease. In:  Duran C, Angell WW, Johnson AD, Oury JH, eds. Recent Progress in Mitral Valve Disease.  Butterworths Scientific Ltd., London, 1984:  Chapter 24, 304 319.
  2) Gray RJ, Czer LSC, Chaux A, Bateman TM, DeRobertis M, Matloff JM:  Double valve replacement. In:  Matloff JM, ed.  Cardiac Valve Replacement:  Current Status.  Martinus Nijhoff Publishing, Boston, 1985: Chapter 13, pp. 99 109.
  3) Gray RJ, Bateman TM, Czer LSC, Conklin CM, Matloff JM:  Therapeutic role of esmolol in hypertension after cardiac surgery.  In:  Kaplan JA, ed.  Esmolol and the Adrenergic Response to Perioperative Stimuli.  Biochemical Information Corp, New York, 1986: pp. 45 52.
  4) Garcia EV, Bateman TM, Berman DS, Maddahi J:  Computer techniques for optimal  radionuclide assessment of the heart.  In:  Gottschalk A, Hoffer PB, Berger JH, Potchen EJ, eds.  Diagnostic Nuclear Medicine:  Second Edition.  Wilkins & Williams, Baltimore, 1988:  Chapter 20, pp. 259 290.
  5) Bateman TM:  Determination of coronary bypass graft patency using cardiac cine CT.  In:  Pohost GM, Higgins CB, Morganroth J, Ritchie JL, Schelbert HR, eds.  New Concepts in Cardiac Imaging 1988.  Year Book Medical Publishers, Chicago, 1988: 217 230.
  6) Berman DS, Maddahi J, Garcia EV, Rozanski A, Shah PK, Bateman TM: Radionuclide studies in coronary artery disease.  In:  Denolin H, Swan JHC, Pisa A, eds.  Complete Coronary Care. Marcel Dekker, Inc. New York, (In press). 
 7) Bateman TM, Whiting JS:  Imaging techniques for the evaluation of coronary bypass grafts.  In:  Brundage BH ed.  Comparative Cardiac Imaging   Function, Flow, Anatomy, Quantitation.  Aspen Publications, Rockville, 1990: 269 279.
  8) Bateman TM:  Perioperative myocardial infarction.  In:  Gray RJ and Matloff JM, eds.  Medical Management of the Cardiac Surgical Patient.  Williams and Wilkins, Baltimore, 1990: 178 185.
  9) Bateman TM:  X Ray Computed Tomography.  In:  Pohost G, O'Rourke R, eds. Principles and Practice of Cardiovascular Imaging.  Little, Brown, and Company, Boston, 1991: 423 451.
  10) Bateman TM:  X Ray Computed Tomography of the Cardiovascular System.  In: Current Problems in Cardiology.  Mosby Year Book, St. Louis, 1991: 767 854.
11) Bateman TM:  Book Review:  Ultrafast Computed Tomography in Cardiac Imaging: Principles and Practice.  Stanford W, Rumberger J eds.  In:  Clinical Cardiology, 1993; 5: 457.
12) Bateman TM, Pohost GM:  Diagnostic value of x ray computed tomography.  In: Cardiovascular Disease and Chest Pain.  Hurst JW ed.  Cahners Healthcare Communications; New York, NY, 1993; 9: 3 8.
13) Bateman TM:  Stress Echocardiography Versus Myocardial Perfusion Scintigraphy. In: Eggli D, ed.  Imaging Insights.  Pragmaton, Chicago, Il. Vol 2, No. 3, 1993: 1 3.
14) Bateman TM (guest editor):  A symposium: the evolving role of cardiac imaging in the assessment of coronary artery disease.  Am J Cardiol 1995; 75: 1D-78D.
15) Cerqueira MD, Bateman TM, Udelson JE.  Today’s Choices for Nuclear Cardiology.  (Tape) GE/TIPTV, February 10, 2000.
16) Cullom SJ, Case JA, Bateman TM.  Attenuation Correction in Myocardial Perfusion SPECT. In: DePuey EG, Garcia EV, Berman DS, eds. Cardiac SPECT Imaging. Lippincott Williams & Wilkins, Philadelphia, Penn, 2001. pgs 89 – 102.
17) Bateman TM, Case JA, Cullom SJ.  Use of nuclear techniques in the assessment of patients before and after cardiac revascularization procedures.  In: Iskandrian AE, Verani MS, eds.  Nuclear Cardiac Imaging: Principles & Applications (3rd Edition); Oxford Univ Press, 2002, New York, New York.
18) Case JA, Cullom SJ, Bateman TM.  Myocardial perfusion SPECT attenuation correction. In: Iskandrian  AE, Verani MS, eds.  Nuclear Cardiac Imaging: Principles & Applications (3rd Edition); Oxford Univ Press, 2002, New York, New York.
19) Bateman TM.  PET myocardial perfusion imaging: making the transition to a clinical routine. Applied  Radiology Vol 3, No. 1,  Anderson Publishing Co, Ocean N.J.
20) Bateman TM.  New concepts in radionuclide evaluation of coronary artery disease. (Tapes, CDs) University of Cincinnati CME Program. April 2003.
21) Case JA, Cullom SJC, Bateman TM.  Introduction to the physics of myocardial perfusion SPECT imaging.  In: Heller GV, Hendel RC, eds. Nuclear Cardiology: A Clinical Approach. McGraw-Hill Companies, Inc, 2003, New York, New York.
22) Bateman TM.  Thallium-201: optimal utilization of the gold standard for myocardial perfusion imaging. In: The Experts’ Guide to Nuclear Cardiology. Thomson Professional Postgraduate Studies. 2004. Pgs 7 – 12
23) Bateman TM. Preface. Atlas Pratique de Scintigraphie Myocardique. Lavoisier, 2006, Paris, France.
24) Bateman TM. Positron emission tomography for myocardial perfusion imaging. In: Hendel RC, Heller GV, eds. PET Perfusion in Nuclear Cardiology: Technical Applications. McGraw Hill Medical Publishing Division, 2007, New York, New York.
25) Bateman T. Editor. PET Champions Series Home Study Program – Cardiology Edition. CardinalHealth. 2007.
26) Bateman TM. Use of nuclear techniques in the assessment of patients before and after cardiac revascularization procedures. In: Iskandrian AE, Garcia EV, eds. Nuclear Cardiac Imaging: Principles & Applications (4th Edition); Oxford Univ Press, New York, New York. 2008: pgs 397 - 416.
27) Case JA, Cullom SJC, Bateman TM. Myocardial perfusion single photon emission computed tomography attenuation correction. In: Iskandrian AE, Garcia EV, eds. Nuclear Cardiac Imaging: Principles & Applications (4th Edition); Oxford Univ Press, New York, New York. 2008: pgs 147 - 160.
28) Bateman TM. Positron emission tomographic techniques and procedures: myocardial perfusion imaging.  In: Heller GV, Mann A, Hendel RC, eds. Nuclear Cardiology: Technical Applications. McGraw Hill Companies, Inc, New York, New York, 2009.
 Peer-Reviewed Articles:
1) Schiff S, Bateman TM, Moffatt R, Davidson R, Berman D:  Diagnostic considerations in cardiomyopathy: unique scintigraphic pattern of diffuse biventricular technetium  99m pyrophosphate uptake in amyloid heart disease.  Am Heart J 103: 562 563, 1982
  2) Bateman TM, Gray R, Maddahi J, Rozanski A, Raymond M, Berman D:  Transient appearance of Q waves in coronary disease during exercise electrocardiography: consideration of mechanisms and clinical importance.  Am Heart J 104: 182 184, 1982
  3) Bateman TM, Gray R, Chaux A, Lee M, DeRobertis M, Berman D, Matloff J:  Right  atrial tamponade complicating cardiac operation: clinical, hemodynamic, and scintigraphic correlates.  J Thorac Cardiovasc Surg 84: 413 419, 1982
  4) Bateman TM, Massumi R, Gray R, Chaux A, DeRobertis M, Brown D, Matloff J, Berman D:  Noninvasive detection of active pericardial bleeding using cardiac blood pool scintigraphy.  Am J Cardiol 51: 329 331, 1983
  5) Weiss MH, Bateman TM, Kass RM, Brown DE, Berman DS, Gray RJ:  Extravascular obstruction of the superior vena cava by hematoma after open heart surgery and diagnosis by scintigraphy.  Am J Cardiol 51: 1229 1231, 1983
  6) Bateman TM, Gray RJ, Raymond MJ, Miyamoto AT, Chaux A, Kass RM, Lee ME, Stewart ME, Matloff JM:  Coronary artery stenoses: relationship between angiographic severity and impact on mean diastolic pressure gradient. J Thorac Cardiovasc Surg 85: 499 507, 1983
  7) Bateman TM, Gray RJ, Czer LSC, Levy RL, Stewart ME, DeRobertis MA, Brown DE, Matloff JM, Swan HJC, Berman DS:  Regional distribution of pulmonary blood volume: an index of pulmonary capillary wedge pressure determined from blood pool scintigraphy.  Am J Cardiol 51: 1404 1408, 1983.
  8) Shellock FG, Riedinger MS, Bateman TM, Gray RJ:  Thermodilution cardiac output determination in hypothermic post cardiac surgery patients: room vs. ice temperature injectate.  Crit Care Med II: 668 670, 1983.
  9) Bateman TM, Garcia E, Maddahi J, Rozanski A, Pantaleo N, Staniloff H, Freeman M, Waxman A, Berman D:  Clinical evaluation of seven pinhole tomography for the detection and localization of coronary artery disease: comparison with planar imaging using quantitative analysis of myocardial thallium 201 distribution and washout after exercise.  Am Heart J 106: 263 271, 1983.
10) Czer L, Hamer A, Murphy F, Bussell J, Chaux A, Bateman TM, Matloff J, Gray R: Transient hemodynamic dysfunction after myocardial revascularization: temperature dependence.  J Thorac Cardiovasc Surg 86: 226 234, 1983.
11) Bateman TM, Gray RJ, Raymond MJ, Chaux A, Czer LSC, Matloff JM:  Arrhythmias and conduction disturbances following cardiac operation for the removal of left atrial myxomas.  J Thorac Cardiovasc Surg 86: 601 607, 1983. 
12) Bateman TM, Czer LSC, Gray RJ, Maddahi J, Raymond MJ, Geft IL, Ganz W, Shah PK, Berman DS: Transient pathologic Q waves during acute ischemic events: an electrocardiographic correlate of stunned but viable myocardium.  Am Heart J 106: 1421 1426, 1983 
 13) Bateman TM, Berman DS: The role of Q waves in exercise testing.  Am Heart J 106: 1448, 1983.
 14) Bateman TM, Maddahi J, Gray RJ, Murphy FL, Garcia EV, Conklin C, Raymond MJ, Stewart ME, Swan HJC, Berman DS:  Diffuse slow washout of myocardial thallium 201: a new scintigraphic indicator of extensive coronary artery disease.  J Am Coll Cardiol 4: 55 64, 1984
 15) Bateman TM, Matloff JM, Gray RJ: Myocardial infarction during coronary artery bypass surgery   benign event or prognostic omen?  Int J Cardiol 6: 259 263, 1984. 
 16) Czer LSC, Gray RJ, DeRobertis MA, Bateman TM, Stewart ME, Chaux A, Matloff JM:  Mitral valve replacement: impact of coronary artery disease and determinants of prognosis after revascularization.  Circulation 70 (Suppl I): 198 207, 1984
 17) Chaux A, Czer LSC, Matloff JM, DeRobertis MA, Stewart ME, Bateman TM, Kass RM, Lee ME, Gray RJ:  The St. Jude bileaflet valve prosthesis: a five year experience.  J Thorac Cardiovasc Surg 88: 706 717, 1984
 18) Bateman TM, Czer LSC, Gray RJ, Kass RM, Raymond MJ, Garcia EV, Chaux A, Matlof JM, Berman DS:  Detection of occult pericardial hemorrhage early after open heart surgery using technetium 99m red blood cell radionuclide ventriculography.  Am Heart J 108: 1198 1206, 1984
 19) Bateman TM, Weiss MH, Czer LSC, Conklin CM, Kass RM, Stewart ME, Matloff J, Gray RJ:  Fascicular conduction disturbances and ischemic heart disease: adverse prognosis despite coronary revascularization.  J Am Coll Cardiol 5: 632 639, 1985
 20) Bateman TM:  Clinical applications of equilibrium radionuclide ventriculography. Appl Radiology 14: 41 50, 1985
 21) Czer LSC, Bateman TM, Gray RJ, Matloff JM:  Mitral valve replacement and associated coronary artery disease.  Cardiol Board Review 2: 99 110, 1985
 22) Czer LSC, Weiss M, Bateman TM, Pfaff JM, DeRobertis M, Eigler N, Vas R, Matloff JM, Gray RJ:  Fibrinolytic therapy of St. Jude valve thrombosis under guidance of digital cinefluoroscopy.  J Am Coll Cardiol 5: 1244 1249, 1985
23) Bateman TM, Czer LSC, Kass RM, Raymond MJ, Chaux A, Matloff JM, Berman DS, Gray RJ: Cardiac causes of shock early after open heart surgery:  etiologic classification by radionuclide ventriculography.  Circulation 91:1153 1161, 1985.
24)  Gray RJ, Bateman TM, Czer LSC, Conklin CM, Matloff JM:  Esmolol   a new utra short acting  beta adrenergic blocking agent for rapid control of heart rate in post operative supraventricular  tachyarrhythmias.  J Am Coll Cardiol 5:1451 1456, 1985.
25) Weiskopt M, Braunstein GD, Bateman TM, Sowers JR, Conklin CM, Matloff JM, Gray RJ: Adrenal  function following coronary bypass surgery.  Am Heart J 110:71 76, 1985.
 26) Gray RJ, Bateman TM, Czer LSC, Conklin CM, Matloff JM:  Use of esmolol in hypertension after cardiac surgery.  Am J Cardiol 56:49F 56F, 1985. 
 27) Gray RJ, Bateman TM:  Recognizing aortic valve disease early.  Diagnosis 8:108 122, 1986.
 28) Gray RJ, Bateman TM:  An updated approach to mitral valve disease.  Diagnosis 8:42 62, 1986.
 29) Czer LSC, Gray RJ, Bateman TM, DeRobertis MA, Resser K, Chaux A, Matloff JM: Hemodynamic differentiation of pathologic and physiologic stenosis in mitral porcine bioprostheses.  J Am Coll Cardiol 7:284 294, 1986.
 30) Bateman TM, Czer LSC, Gray RJ, Berman DS, Matloff JM:  Determining the causes of cardiac shock early after open heart surgery.  Cardiology Board Review 3:77 82, 1986.
 31) Bateman TM, Matloff JM:  Radionuclide ventriculography for assessing cardiac shock early after open heart surgery.  Acute Care 11:48 52, 1986.
 32) Bateman TM, Gray RJ, Whiting JS, Matloff JM, Berman DS, Forrester JS:  Cine computed tomographic evaluation of aorto coronary bypass graft patency.  J Am Coll Cardiol 8:693 698, 1986.
 33) Bateman TM:  Cine CT's speed makes it a preferred cardiac tool.  Diagnostic Imaging 8:112 115, 1986.
 34) Sethna DH, Bateman TM, Whiting JS, Forrester JS:  Comprehensive and quantitative cardiac assessment using cine CT:  Description of a new clinical diagnostic modality.  Am J Cardiac Imaging 1:18 28, 1987.
 35) Harold JG, Bateman TM, Czer LSC, Chaux A, Matloff JM, Gray RJ:  Left ventricular rupture complicating mitral valve replacement:  relationship to recent infarction.  J Am Coll Cardiol 9:277 282, 1987.
 36) Bateman TM, Garcia EV, Kass RM, Raymond MJ, Stewart ME, Gray RJ, Matloff JM, Berman DS:  Experimental evaluation of technetium 99m red blood cell radionuclide ventriculography for detecting pericardial bleeding.  Am Heart J 113:977 983, 1987.
 37) Gray RJ, Bateman TM, Czer LSC, Conklin CM, Matloff JM:  Comparison of esmolol and nitroprusside for acute post cardiac surgical hypertension.  Am J Cardiol 59:887 891, 1987.
38) Bateman TM, Gray RJ, Whiting JS, Sethna DH, Berman DS, Matloff JM, Swan HJC, Forrester JS:  Prospective evaluation of ultrafast cardiac computed tomography for determination of coronary bypass graft patency.  Circulation 75:1018 1024, 1987.
39) Czer LSC, Bateman TM, Gray RJ, Raymond M, Stewart ME, Lee S, Goldfinger D, Chaux A, Matloff JM: Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass:  Reduction in blood product usage with desmopressin.  J Am Coll Cardiol 9:1180 1183, 1987.
 40) Bateman TM, Whiting JS, Chaux A, Berman DS, Forrester JS:  Comprehensive noninvasive evaluation of left atrial myxomas using cardiac cine computed tomography.  J Am Coll Cardiol 9:1180 1183, 1987.
 41) Bateman TM:  Current clinical utility of equilibrium radionuclide ventriculography. Cardiol Mgmt 2:10 33, 1988. 
 42) Stanford W, Brundage BH, McMillan R, Bateman TM, Chomka E, Lipton MJ, White CW, Wilson RF, Marcus ML:  Sensitivity and specificity of assessing coronary bypass graft patency with ultrafast computed tomography:  Results of a multicenter study.  J Am Coll Cardiol 12:1 7, 1988. 
 43) Bateman TM, Whiting JS:  Ultrafast CT for determination of aortocoronary bypass graft patency and measurement of graft blood flow.  Cardio 5:19 22, 1988.
 44) Bateman TM, Fisher JK:  Magnetic resonance imaging in coronary heart disease:  A major breakthrough for precise noninvasive cardiac evaluation?  Am J Card Imaging 3:88 90, 1989.
 45) O'Keefe JH Jr, Rutherford BD, McConahay DR, Ligon RW, Johnson WL Jr, Giorgi LV, Crockett JE, McCallister BD, Conn RD, Gura GM Jr, Good TH, Steinhaus DM, Bateman TM, Shimshak TM,  Hartzler GO:  Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction.  Am J Cardiol 64:1221 1230, 1989.
 46) Bateman TM:  Nuclear Cardiology:  Whose Specialty is it?  Cardio 7:3,126, 1990.
 47) Bateman TM, O'Keefe JH Jr:  Pharmacological (stress) perfusion scintigraphy:  methods, advantages, and applications.  Am J Card Imaging 6:3 15, 1992.
 48) O'Keefe JH Jr, McCallister BD, Bateman TM, Kuenlein DL, Ligon RW, Hartzler GO: Ineffectiveness of colchicine for the prevention of restenosis following coronary angioplasty.  J Am Coll Cardiol 19:1597 1600, 1992.
 49) O'Keefe JH Jr, Bateman TM, Silvestri R, Barnhart C: Safety and diagnostic accuracy of adenosine thallium 201 scintigraphy in patients unable to exercise and those with left bundle branch block.  Am Heart J 124: 614 621, 1992.
 50) O'Keefe JH Jr, Bateman TM, Barnhart CS:  Adenosine thallium 201 is superior to exercise thallium 201 for the detection of coronary artery disease in patients with left bundle branch block.  J Am Coll Cardiol 21: 1332 1338, 1993.
 51) O'Keefe JH Jr, Barnhart C, Bateman TM:  Adenosine:  preferred adjunct to thallium imaging for patients with left bundle branch block.  Cardiol Board Review  11:  42 48, 1994.
 52) Bateman TM:  Stress echo and nuclear perfusion imaging for the diagnosis and evaluation of coronary disease:  the nuclear perspective.  Primary Cardiology 20: 9-18, 1994.
 53) Bateman TM, Kolobrodov V, Vasin A, O'Keefe JH, Jr:  Extended acquisition for minimizing attenuation artifact in SPECT cardiac perfusion imaging.  J Nucl Med 35: 625-627, 1994.
 54) Van Train KF, Garcia EV, Maddahi J, Areeda J, Cooke CD, Kiat H, Silagan G, Folks R, Friedman J, Matzer L, Germano G, Bateman TM, Ziffer J, DePuey, EG, Fink-Bennet D, Cloniger K, Berman DS:  Multicenter trial validation for quantitative analysis of same-day rest-stress technetium-99m sestamibi myocardial tomograms.  J. Nucl Med 35: 609-618, 1994.
 55) O'Keefe JH Jr, Grines CL, DeWood MA, Bateman TM, Christian TF, Gibbons RJ:  Factors influencing myocardial salvage with primary angioplasty.  J Nucl Cardiol 2: 35-41, 1995.
 56) O'Keefe JH Jr, Bateman TM, Handlin LR, Barnhart C: Four versus six-minute infusion protocol for adenosine thallium-201 SPECT imaging.  Am Heart J 129: 482-487, 1995.
 57) O'Keefe JH Jr., Sayed-Taha K, Gibson W, Christian TF, Bateman TM, Gibbons RJ:  Do patients with left circumflex coronary artery-related acute myocardial infarction without ST segment elevation benefit from reperfusion therapy?  Am J Cardiol 75: 718-720, 1995. 
 58) Ritchie JL, Bateman TM, Bonow RO, Crawford MH, Gibbons RJ, Hall RF, O'Rourke RA, Parisi AF, Verani MS:  Guidelines for clinical use of cardiac radionuclide imaging.  J Am Coll Cardiol 25:517-547, 1995; J Nucl Cardiol 2:172-192,1995; Circulation 91:1278-1303, 1995.
 59) Bateman TM, O'Keefe JH Jr, Dong VM, Barnhart C, Ligon RW:  Coronary angiography rates following stress SPECT scintigraphy.  J Nucl Cardiol 2: 217-223, 1995.
 60) Bateman TM:  The evolving role of cardiac imaging in the assessment of coronary artery disease.  Am J Cardiol 75:1D-2D,1995.
 61) O'Keefe JH Jr, Barnhart CS, Bateman TM:  Comparison of stress echocardiography and stress myocardial perfusion scintigraphy for diagnosing coronary artery disease and assessing its severity.  Am J Cardiol 75:25D-34D,1995.
 62) O'Keefe JH Jr, Bateman TM, Lavie CJ Jr: Are invasive procedures overused in angina patients? Postgraduate Medicine 98: 124-142, 1995.
 63) O'Keefe JH Jr, Conn RD, Lavie CJ Jr, Bateman TM: The new paradigm for coronary artery disease: altering risk factors, atherosclerotic plaques, and clinical prognosis. Mayo Clinic Proceedings 71: 957-965, 1996.
 64) O'Keefe JH Jr, Grines CL, DeWood MA, Schaer GL, Browne K, Magorien RD, Kalbfleisch JM, Fletcher WO, Bateman TM, Gibbons RJ: Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 78: 747-750, 1996.
 65) Bateman TM, O'Keefe JH, Williams ME. Incremental value of myocardial perfusion imaging in assessment of patients with known or suspected coronary artery disease. Curr Opinion Cardiol 11: 613-620, 1996. 
 66) Bateman TM, Stowers SA, Herndon WM. Statement on mobile and remote-site provision of nuclear cardiology imaging services: ASNC position paper. J Nucl Cardiol 4: 174-177, 1997.
 67) Bateman TM. Clinical relevance of a normal stress-rest myocardial perfusion scintigraphic study: ASNC position paper. J Nucl Cardiol 4:172-173, 1997.
 68) Bateman TM, O'Keefe JH, Williams ME. Design and implementation of a nuclear cardiology testing facility in a private-practice cardiology office setting. J Nucl Cardiol 4: 156-163, 1997.
 69) Wackers FJTh, Bateman TM. Blueprint of the certification exam in nuclear cardiology.  J Nucl Cardiol 4: 164-168, 1997.
 70) Bateman TM. Nuclear cardiology in private practice. J Nucl Cardiol 4: S184-5188, 1997.
 71) Bateman TM.  Impact of myocardial perfusion imaging on patient management: implications for cost-effectiveness. Perspectives in Nucl Cardiol 2:3-6, 1997.
 72) Gum PA, O'Keefe JH, Borkon AM, Spertus JA, Bateman TM, McGraw JP, Sherwani K, Vacek J, McCallister BD. Bypass surgery versus coronary angioplasty for revascularization of treated diabetic patients. Circulation 96 (Suppl. II):7-10, 1997.
 73) O'Keefe JH, Bateman TM, Ligon RW, Case JH, Cullom SJ, Barnhart C, Spertus J. Outcome of medical versus invasive treatment strategies for non-high risk ischemic heart disease. J Nucl Cardiol 5:28-33, 1998.
 74) Ullyot DJ, Drozda JP, Messer JV, Bateman TM, Port SC, Thomas GS.  American College of Cardiology Policy Statement on Nuclear Cardiology Services.  J Am Coll Cardiol 31:720-721, 1998.
 75) Cullom SJ, Bateman TM, Case JA.  Electrocardiographically-gated myocardial perfusion SPECT:  Technical principles and quality control considerations.  J Nucl Cardiol 5: 418-425, 1998.
 76) Bateman TM, Cullom SJ, Case JA.  Wide-area networking in nuclear Cardiology.  J Nucl Cardiol 6: 211-218, 1999. 
 77) Hendel RC, Gibbons RJ, Bateman TM.  Use of rotating (cine) planar projection images in the interpretation of a tomographic myocardial perfusion study.  J Nucl Cardiol 6: 234-240, 1999.
 78) Bateman TM.  Bridging the gap between new discoveries and clinical implementation. J Nucl Cardiol 6: 247, 1999.
 79) Blankenship JC, Bateman TM, Haines DE, Pearlman AS, Schoenfeld MH, Sigel CJ, Wolk MJ, Wood DL. ACC Expert Consensus Document on Ethical Coding and Billing Practices for Cardiovascular Medicine Specialists.  J Am Coll Cardiol 33:1076-1086, 1999.
80) Bateman TM.  Key elements of a successful nuclear cardiology practice.  J Nucl Cardiol 6:378, 1999.
81) O’Keefe JH, Bateman TM, Gibbons RJ.  Exercise echocardiography versus exercise SPECT testing.  JAMA 282:1622, 1999.
82) Bateman TM.  Nuclear cardiology in 2000.  J Nucl Cardiol 6:552, 1999.
83) O'Keefe JH, Magalski A, Stevens TL, Bresnahan DR, Krueger SK, Bateman TM.  Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure. J Nucl Cardiol 7:3-7, 2000.
84) Bateman TM – ASNC in the New Millennium.  J Nucl Cardiol 7:92, 2000
85) Cullom SJ, Case JA, Bateman TM.  Attenuation correction for cardiac SPECT: clinical and developmental challenges.  J Nucl Med 41: 860-862, 2000.
86) Bybee KA, O'Keefe JH, Harris WS, Garg S, George SJ, Bateman TM.  Lipid risk factor correlates of ischemic heart disease as diagnosed by myocardial perfusion scintigraphy.  Prev Cardiol 3: 154-159, 2000.
87) Bateman TM.  Nuclear cardiology: gateway to cardiac cath. Diagnostic Imaging 17 – 19. 2000.
88) Chee NK, Bateman TM.  Cost-effectiveness of stress echocardiography and nuclear perfusion imaging. Progress in Cardiovascular Diseases 43: 197-214, 2000.
89) Shaw LJ, Iskandrian AE, Hachamovitch R, Germano G, Lewin HC, Bateman TM, Berman DS. Evidence-based risk assessment in noninvasive imaging. J Nucl Med 42: 1424 – 1436, 2001. 
90) Hendel RC, Corbett JA, Cullom SJ, DePuey EG, Garcia EV, Bateman TM. The value and practice of attenuation correction for myocardial perfusion SPECT imaging: a joint position paper from the American Society of Nuclear Cardiology and the Society of Nuclear Medicine. J Nucl Med 43: 273 – 280, 2002. 
91) Hendel RC, Corbett JA, Cullom SJ, DePuey EG, Garcia EV, Bateman TM. The value and practice of attenuation correction for myocardial perfusion SPECT imaging: a joint position paper from the American Society of Nuclear Cardiology and the Society of Nuclear Medicine. J Nucl Cardiol 9: 135 – 143, 2002. 
92) Moser KW, O’Keefe JH, Bateman TM, McGhie AI. Coronary calcium screening in asymptomatic patients as a guide to risk factor modification and stress myocardial perfusion imaging. J Nucl Cardiol 10: 590 – 598, 2003.
93) Klocke FJ, Baird MG, BatemanTM, et al. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging. J Am Coll Cardiol 42: 1318 – 1333, 2004.
94) Heller GV, Links J, Bateman TM, Ziffer JA, Ficaro E, Cohen MC, Hendel RC. American Society of Nuclear Cardiology and Society of Nuclear Medicine Joint Position Statement: Attenuation Correction of Myocardial Perfusion SPECT Scintigraphy. J Nucl Cardiol 11: 229 – 230, 2004.
95) Moser KW, Bateman TM, O’Keefe JH, McGhie AI. Interscan variability of coronary artery calcium quantification using an electrocardiographically pulsed spiral computed tomographic protocol. Am J Cardiol 93: 1153 – 1155, 2004.
96) Bateman TM, Prvulovich E. Assessment of prognosis in chronic coronary artery disease. Heart 90 (Supplement V): 10 – 25, 2004.
 97) Heller GH, Bateman TM, and the Multicenter Investigators. Clinical value of attenuation correction in stress-only Tc-99m sestamibi SPECT imaging. J Nucl Cardiol 11: 273 – 281, 2004.
 98) Grossman GB, Garcia EV, Bateman TM, Heller GV, Johnson LL, Folks RD, Cullom SJ, Galt JR, Case JA, Santana CA, Halkar RK. Quantitative technetium-99m sestamibi attenuation corrected SPECT: development and multicenter trial validation of myocardial perfusion stress gender-independent normal database in an obese population. J Nucl Cardiol 11: 263 – 272, 2004.
 99) Bateman TM. Nuclear cardiology: the basics – how to set up and maintain a laboratory. (Book review). J Nucl Cardiol 11: 364 – 365, 2004.
 100) Bateman TM, Thomas GS. Challenges and strategies in the provision of high-quality nuclear cardiology imaging services in office-based nuclear cardiology. J Nucl Cardiol 11: 245 – 252, 2004.
101) Bateman TM. Cardiac positron emission tomography and the role of adenosine pharmacologic stress. Am J Cardiol 94 (Supplement): 19D – 25D, 2004.
 102) Bateman TM, Cullom SJ. Attenuation correction single photon emission computed tomography myocardial perfusion imaging. Semin Nucl Med 35: 37 – 51, 2005.
 103) O’Keefe JH, Abuissa H, Jones PG, Thompson RC, Bateman TM, McGhie AI, Ramza BM, Steinhaus DM. Effect of chronic right ventricular apical pacing on left ventricular function. Am J Cardiol 95: 771 – 773, 2005.
 104) Thompson RC, Heller GV, Johnson LL, Case JA, Cullom SJ, Moutray KL, Garcia EV, Bateman TM. Value of attenuation correction on ECG-gated SPECT myocardial perfusion imaging related to body mass index. J Nucl Cardiol 12: 195 – 202, 2005.
 105) Thompson RC, McGhie AI, Moser KW, O’Keefe JH, Stevens TL, House J, Fritsch N, Bateman TM. Clinical utility of coronary calcium scoring after nonischemic myocardial perfusion imaging. J Nucl Cardiol 12: 392-400, 2005.
 106) Dilsizian V, Bateman TM, Bergmann SR, Des Prez R, Magram M, Goodbody AE, Babich JW, Udelson JE. Metabolic imaging with B-Methly-p-I123-Iodophenyl-pentadecanoic acid (BMIPP) identifies ischemic memory after demand ischemia. Circulation 112: 2169 – 2174, 2005.
 107) Hendel RC, Bateman TM, Cerqueira MD, Iskandrian AE, Leppo JA, Blackburn B, Mahmarian JJ. Initial clinical experience with Regadenoson, a novel selective A2a agonist, for pharmacologic stress single-photon emission computed tomography myocardial  perfusion imaging. J Am Coll Cardiol 46: 2069 – 2075, 2005.
 108) Bateman TM, Heller GV, McGhie AI, Friedman JD, Case JA, Bryngelson JR, Hertenstein GK, Moutray KL, Reid K, Cullom SJC. Diagnostic accuracy of rest/stress ECG-gated rubidium-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol 13: 24 – 33, 2006.
 109) Boger LA, Volker LL, Hertenstein GK, Bateman TM.  Best patient preparation before and during radionuclide myocardial perfusion imaging studies. J Nucl Cardiol 13: 98 – 110, 2006.
 110) Rivero A, Santana C, Folks RD, Esteves F, Verdes L, Esiashvili S, Grossman GB, Halkar RK, Bateman TM, Garcia EV. Attenuation correction reveals gender-related differences in the normal values of transient ischemic dilation index in rest-exercise stress sestamibi myocardial perfusion imaging. J Nucl Cardiol 13: 338 – 344, 2006.
 111) Bateman TM, Heller GV, Cullom SJ. Letter to the Editor. J Nucl Cardiol 13: 591 – 592, 2006.
 112) Boger LA, Volker LL, Hertenstein GK, Bateman TM. Letter to the Editor. J Nucl Cardiol 13: 731-732, 2006.
 113) Machac J, Bacharach SL, Bateman TM, Bax JJ, Beanlands R, Bengel F, Bergmann SR, Brunken RC, Case J, Delbeke D, DiCarli MF, Garcia EV, Goldstein RA, Gropler RJ, Travin M, Patterson R, Schelbert HR. ASNC On-Line Guidelines: Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol 13: e121 – e151, 2006.
 114) Singh B, Bateman TM, Case JA, Heller G. Attenuation artifact, attenuation correction, and the future of myocardial perfusion SPECT. J Nucl Cardiol 14: 153 – 164, 2007.
 115) Case JA, Hsu BL, Bateman TM, Cullom SJ. A Bayesian iterative transmission gradient reconstruction algorithm for cardiac SPECT attenuation correction. J Nucl Cardiol 14: 324 – 333, 2007.
 116) Hsu BL, Case JA, Moser KW, Bateman TM, Cullom SJ. Reconstruction of rapidly acquired Germanium-68 transmission scans for cardiac PET attenuation correction. J Nucl Cardiol 14: 706 – 714, 2007.
 117) Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC, Lieu H, Mahmarian JJ, Olmsted A, Underwood SR, Vitola J, Wang W. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 14: 645 – 658, 2007. 
 118) Bybee KA, Bateman TM. Symptom-limited exercise during vasodilator stress: best of both worlds? J Nucl Cardiol 15: 3 – 6, 2008.
 119) Bateman TM. Business aspects of cardiovascular computed tomography: tackling the challenges. J Am Coll Cardiol Img 1: 111 – 118, 2008.
 120) Lakkireddy D, Aronow WS, Bateman T, McGhie I, Nair C, Khan IA.  Does beta blocker therapy affect the diagnostic accuracy of adenosine single-photon-emission computed tomographic myocardial perfusion imaging? Am J Therapeutics 15: 19 – 23, 2008.